Spiritual Quotes – Lifestyle

Author: BioAge Labs, Inc.

BioAge to Host R&D Day Focused on NLRP3 Inhibition on May 8, 2026

May 4, 2026
BioAge Reports Positive Phase 1 Data for BGE-102, a Novel Oral NLRP3 Inhibitor, Demonstrating Potential Best-in-Class Reductions in hsCRP

April 21, 2026
BioAge Labs to Present at 25th Annual Needham Virtual Healthcare Conference

April 13, 2026
BioAge Labs Reports Full Year 2025 Financial Results and Provides Business Updates from the Fourth Quarter of 2025

March 24, 2026